The Conversation: New Outsourcing

Innovex Conversation

Return to mainpage

Bookmark this page

Share with del.icio.us  Digg this  RSS Feed  Fcebook  Technorati

Subscribe to Email Based on Your Interests

Set preferences

The Conversation: New Outsourcing

Well apparently not. Now there is mounting evidence that Pharmaceutical businesses are demanding much more: multi-skilled teams, split between various countries, super- flexible resourcing, demonstrable outcomes, improved productivity and outsourced or shared risk. Traditional outsourcing is evolving, that why we call it New Outsourcing.

The podcasts

UK news anchor Siân Jones talks about the pros and cons of New Outsourcing.
Listen >>

Customer evidence

How New Outsourcing provides the right skills at the right time.
Find out more >>

Research report

Beth Rogers of Portsmouth Business School presents the case for outsourcing.
Read More >>

Data

The New Outsourcing effect: Graphic evidence?
Find out more >>